4 October 2023
| Marcia Zondervan, Hannah Faal, Covadonga Bascaran
|
EYE - General
The VISION 2020 LINKS & Networks Programme has been writing regular articles in Eye News about its capacity-strengthening activities in low- and middle-income countries (LMICs) for more than a decade. This, the first International Issue, is a landmark for Eye...
In the context of the COVID-19 pandemic, video consultations (VC) in eye care have been adopted in some regions and hospitals as a way of replacing some face to face ophthalmic consultations. I would like to use this column to...
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
Vison Care for Homeless People (VCHP) was first established in 2003 with the aim to provide eye tests and glasses free of charge to people living in shelters, hostels or who are sleeping rough. Today, we remain the only national...
1 February 2019
| Covadonga Bascaran, Ellen Heinemann, Carla Ayres Musa, Donovan Cacho, Andrew Smith
|
EYE - Vitreo-Retinal, EYE - General
The rise of diabetes mellitus (DM) and its complications is a public health concern in the Caribbean. The Caribbean Diabetic Retinopathy (DR) Programme, managed by the London School of Hygiene & Tropical Medicine (LSHTM) and funded by the Queen Elizabeth...
In a recent discussion with colleagues, someone recognised that many, when asked what they do, say, “I am a doctor”. Rather than “I work as a doctor”. This sense of belonging, pride and duty comes with responsibility. Becoming a surgeon,...
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...
1 August 2017
| Winifred Nolan, Nick Strouthidis, Keith Barton
|
EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...
1 April 2020
| Marcia Zondervan, Gerald Msukwa, Josiah Onyango, Mike Burdon, Allen Foster (Prof)
|
EYE - General
As other articles in this series (IN FOCUS Apr 2020) demonstrate, the year 2020 is highly significant in the eye care field. Naming a global initiative ‘VISION 2020: The Right to Sight’ in 1999 was a daring way to focus...
2 October 2025
| Islay Mactaggart, Ian McCormick, Jacqueline Ramke, Andrew Bastawrous, Matthew J Burton
|
EYE - General
In this paper we will discuss The Rapid Assessment of Avoidable Blindness (RAAB), a survey methodology that has become the single largest source of population eye health data globally. The origins of RAAB The RAAB is a rapid, population-based survey...
This is a retrospective review of 56 patients with cicatricial conjunctivitis, including 25 eyes that received sub-conjunctival injections of 25-50mg of 5-fluorouracil (5-FU) as part of their treatment. Thirty-seven patients had ocular cicatricial pemphigoid (OCP) and 19 had Stevens-Johnson syndrome...
Managing patients who attend a practice with symptoms of flashes and floaters is a regular occurrence in community optometric practice. It’s often very distressing for patients; symptoms can be quite dramatic and an internet search can indicate imminent blindness from...